News Focus
News Focus
Followers 1535
Posts 7856
Boards Moderated 4
Alias Born 02/26/2010

Re: nodummy post# 173798

Thursday, 06/11/2020 1:23:42 PM

Thursday, June 11, 2020 1:23:42 PM

Post# of 234106
ARYC - Dr. Julie Taguchi also charged

Taguchi is Arrayit's lab director

https://www.scribd.com/document/465259223/A-Ryc-Taguchi

Looks like she is Physician #1 referred to in the Mark Schena criminal case:


https://www.justice.gov/usao-ndca/pr/medical-technology-company-president-charged-scheme-defraud-investors-and-health-care

https://www.justice.gov/usao-ndca/press-release/file/1283956/download

Physician #1 is a medical doctor who is licensed in the State of California and a participating provider with Medicare. Physician #1 has proffered with the government pursuant to a Kastigar agreement and has signed an agreement to plead guilty to one count of conspiracy to commit health care fraud, in violation of 18 U.S.C. § 1349.

Physician #1 stated that s/he conspired to commit health care fraud with SCHENA and others. Physician #1 stated it is not medically necessary to test every patient for 120 allergens using the Arrayit test. Physician #1 stated that SCHENA requested the NPI number of Physician #1 and that Physician #1 later discovered that Arrayit submitted claims to Medicare and private insurance plans using Physician #1’s NPI to represent that Physician #1 had ordered allergy testing for patients whom Physician #1 had never seen. Many of these patients were located outside of the State of California and never received treatment from Physician #1. Physician #1 stated that an executive of Arrayit (Executive #1) paid Physician #1 illegal kickbacks in the form of insurance reimbursement checks in exchange for Arrayit’s ordering of allergy testing for patients whom Physician #1 had never seen. In addition, Physician #1 stated that SCHENA and others submitted false and fraudulent documentation to regulatory bodies in order to obtain regulatory approval to allow Arrayit to conduct laboratory testing.


From the Taguchi complaint:





Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today